Author

Ewa Krecipro-Nizińska

Observed names: E. Krecipro-Nizinska, Ewa Krecipro Nizinska, Ewa Krecipro-Nizinska, Krecipro-Nizińska, Ewa

Observed institution: Wroclaw Medical University

OpenAlex ID: A5027337186

Establishing Reference Values in Healthy Participants for the Cardiac Troponin T High-Sensitivity Gen 6 Assay: REF-TSIX Global Reference Study

2026 · Lori B Daniels, Christian Mueller, et al. · Clinical Chemistry · 14

Immunogenicity and Safety of Co-administration of Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine With 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥60 Years: A Randomized, Non-inferiority Trial

2026 · Isabel Leroux-Roels, Muriel Lins, et al. · Clinical Infectious Diseases · 2

Clinical performance of the next generation Elecsys Troponin T high-sensitivity Gen 6 assay in acute coronary syndrome (PERFORM-TSIX): study design

2026 · Lori B. Daniels, Evangelos Giannitsis, et al. · Clinical Research in Cardiology · 2

LUMIADE 3: Therapeutic Equivalence of Denosumab Biosimilar FKS518 to Reference Product in Postmenopausal Osteoporosis

2025 · Ewa Krecipro-Nizinska, Wojciech Pluskiewicz, et al. · Journal of the Endocrine Society · 1

[Nodular changes in lungs in a patient with rheumatoid arthritis. Diagnostic and therapeutic difficulties. Case report].

2010 · Ewa Krecipro-Nizińska, Ewa Morgiel, et al. · PubMed · 1

Sustained Efficacy, Safety and Immunogenicity Following Single Switch from Reference Product Denosumab to FKS518 Proposed Biosimilar in Postmenopausal Women with Osteoporosis (Results from the Pivotal LUMIADE 3 Study)

2026 · Serge Ferrari, Ewa Krecipro-Nizinska, et al. · The Journal of Rheumatology

OP0055 Sustained Efficacy, Safety and Immunogenicity Following Single Switch from Originator Denosumab to FKS518 Proposed Biosimilar in Postmenopausal Women with Osteoporosis (results from the pivotal LUMIADE 3 study)

2025 · S. Ferrari, E. Krecipro-Nizinska, et al. · Annals of the Rheumatic Diseases

419P A randomized, controlled, multicenter study to evaluate the therapeutic equivalence between FKS518 proposed biosimilar to denosumab and the reference denosumab in postmenopausal women with osteoporosis (LUMIADE-3 study)

2025 · I. Valter, E. Krecipro-Nizinska, et al. · ESMO Open

Współistnienie łuszczycowego zapalenia stawów oraz choroby Leśniowskiego-Crohna. Wskazana konsultacja gastroenterologa i możliwości terapeutyczne – opis przypadku

2021 · Ewa Krecipro-Nizińska, Anna Durazińska, et al. · Reumatologia News

Nieswoiste zapalenie jelit a dolegliwości stawowe – opis przypadku

2018 · Ewa Krecipro-Nizińska, Piotr Wiland · Reumatologia News

[Bilateral exophthalmos requiring rheumatologic consultation. A case of the Churg-Strauss syndrome].

2012 · Ewa Morgiel, Ewa Krecipro-Nizińska, et al. · PubMed

Works count: 12

Citation count: 20

H-index: 2

I10-index: 1